Medication info

Boryung Mucomist Solution 10% (Acetylcysteine)

OTC medicationSolution
Ingredient · strength
Acetylcysteine›10g / 100mL
Manufacturer / importer
Boryung Co., Ltd.
Appearance
A colorless, transparent solution in a colorless, translucent plastic container.
Packaging
10 bottles/box[((8mL/bottle)x5) x 2], 10 bottles/box[((3mL/bottle)x5) x 2)]
Approval status
Active

MFDS item code 202200263 · Approved 2022.01.14 · Insurance code 641907841

Summary

Main use
Relief of difficulty expectorating sputum (including in asthma and bronchitis); adjunctive treatment before and after examinations and procedures
Who uses it
Adults
Adult dosage
The 20% solution may be diluted to a lower concentration using sodium chloride injection, sodium chloride inhalation solution, sterile water for injection, or sterile water for inhalation. The 10% solution may be used undiluted. 1. Nebulization using a face mask, mouthpiece, or tracheostomy: Nebulize 1 ~ 10 mL of the 20% solution or 2 ~ 20 mL of the 10% solution every 2 ~ 6 hours. The recommended dose is 3 ~ 5 mL of the 20% solution or 6 ~ 10mL of the 10% solution, nebulized 3 ~ 4 times daily. 2. Nebulization using a mist tent or inhalator (Croupette): This method is used when specifically needed and should be individualized according to the patient’s requirements and the convenience of the administration method. Large volumes of solution are required for this method, sometimes up to approximately 300 mL per treatment. The recommended amount should be sufficient to maintain a very dense mist in the tent or inhalator throughout the treatment period. Intermittent or continuous administration over a prolonged period is preferred. 3. Direct instillation 1) Administer 1 ~ 2 mL of the 10% or 20% solution every hour. 2) For routine treatment of patients with a tracheostomy, administer 1 ~ 2 mL of the 10% or 20% solution through the tracheostomy every 1 ~ 4 hours. 3) When administered directly to a specific part of the bronchial tree by inserting a small plastic catheter into the trachea under local anesthesia and direct incision, administer 2 ~ 5 mL of the 20% solution every 1 ~ 4 hours using a syringe connected to the catheter. 4) When administered using a percutaneous intrabronchial catheter, administer 1 ~ 2 mL of the 20% solution or 2 ~ 4mL of the 10% solution every 1 ~ 4 hours using a syringe connected to the catheter. 4. Diagnostic bronchography Before performing bronchography, administer 1 ~ 2 mL of the 20% solution or 2 ~ 4mL of the 10% solution by nebulization 2 ~ 3 times or by intrabronchial instillation.

Ingredients

Manufacturer
Boryung Co., Ltd.

Efficacy & effects

Relief of difficulty expectorating sputum (including in asthma and bronchitis); adjunctive treatment before and after examinations and procedures

  • Difficulty in expectoration
  • bronchial asthma
  • chronic bronchitis
  • bronchiectasis
  • pulmonary tuberculosis
  • emphysema
  • upper respiratory tract infections
  • pharyngolaryngeal inflammation
  • lung abscess
  • pneumonia
  • cystic fibrosis
  • post-surgical pulmonary complications.
View approved original text

Difficulty in expectoration can occur in various respiratory diseases and infections such as bronchial asthma, chronic bronchitis, bronchiectasis, pulmonary tuberculosis, and emphysema. Additionally, conditions such as upper respiratory tract infections, lung abscesses, pneumonia, cystic fibrosis, and post-surgical pulmonary complications can lead to difficulty in expectoration. This medication is used to aid in expectoration and improve breathing, thus alleviating symptoms in these diseases. It is also effectively used before and after procedures such as bronchography, bronchoscopy, lung cancer cytology tests, and tracheostomy. Therefore, this medication is used to improve expectoration in respiratory-related diseases and treatment situations.

Dosage and Administration

Adult dosage

The 20% solution may be diluted to a lower concentration using sodium chloride injection, sodium chloride inhalation solution, sterile water for injection, or sterile water for inhalation. The 10% solution may be used undiluted. 1. Nebulization using a face mask, mouthpiece, or tracheostomy: Nebulize 1 ~ 10 mL of the 20% solution or 2 ~ 20 mL of the 10% solution every 2 ~ 6 hours. The recommended dose is 3 ~ 5 mL of the 20% solution or 6 ~ 10mL of the 10% solution, nebulized 3 ~ 4 times daily. 2. Nebulization using a mist tent or inhalator (Croupette): This method is used when specifically needed and should be individualized according to the patient’s requirements and the convenience of the administration method. Large volumes of solution are required for this method, sometimes up to approximately 300 mL per treatment. The recommended amount should be sufficient to maintain a very dense mist in the tent or inhalator throughout the treatment period. Intermittent or continuous administration over a prolonged period is preferred. 3. Direct instillation 1) Administer 1 ~ 2 mL of the 10% or 20% solution every hour. 2) For routine treatment of patients with a tracheostomy, administer 1 ~ 2 mL of the 10% or 20% solution through the tracheostomy every 1 ~ 4 hours. 3) When administered directly to a specific part of the bronchial tree by inserting a small plastic catheter into the trachea under local anesthesia and direct incision, administer 2 ~ 5 mL of the 20% solution every 1 ~ 4 hours using a syringe connected to the catheter. 4) When administered using a percutaneous intrabronchial catheter, administer 1 ~ 2 mL of the 20% solution or 2 ~ 4mL of the 10% solution every 1 ~ 4 hours using a syringe connected to the catheter. 4. Diagnostic bronchography Before performing bronchography, administer 1 ~ 2 mL of the 20% solution or 2 ~ 4mL of the 10% solution by nebulization 2 ~ 3 times or by intrabronchial instillation.

Precautions

This medication should not be used by individuals who are allergic to this drug or any of its ingredients. Patients with bronchial asthma or respiratory dysfunction should consult a doctor or pharmacist before using this medication, as it may cause bronchospasm. If any abnormal symptoms occur, use should be discontinued immediately and appropriate treatment should be sought. Pregnant women or those who may become pregnant should only use this medication if absolutely necessary, and nursing mothers should use it cautiously as it may be secreted in breast milk. Elderly patients and children should use this medication with caution as its safety has not been thoroughly established for these populations. If symptoms such as sudden shortness of breath, bronchial obstruction, or allergic reactions like rashes occur while using this medication, use should be stopped immediately, and a doctor should be consulted. Gastrointestinal symptoms such as nausea, vomiting, or loss of appetite may occasionally occur, and in rare cases, symptoms such as hemoptysis, chills, fever, drowsiness, and chest tightness may also manifest. As bronchial secretions may increase, symptoms should be closely monitored, and appropriate measures should be taken if expectoration becomes difficult. The effectiveness of this medication may decrease when used with antibiotics; therefore, it is advisable to administer them separately when used together. This medication is not to be used as an injection or eye drops, and while spraying, a mask may attach to the face but can be easily removed with water. Elderly patients should be closely monitored due to potentially weakened physical function and usage should be cautious. Keep this medication out of reach of children, and store it in its original container to prevent misuse or degradation of quality when transferred to another container. The metal or rubber parts used in the nebulizer should be cleaned immediately after use; slight staining may occur after cleaning, but it does not affect the drug's efficacy. Certain antibiotics may precipitate or discolor when mixed with this medication, so they should not be combined. To prevent an excessive concentration of the drug during nebulization, it is advisable to dilute it, and any unused medication should be discarded immediately after opening.

Side effects

  • Bronchial obstruction
  • bronchospasm
  • anaphylaxis
  • rash
  • dyspnea
  • mild intoxication
  • nausea
  • vomiting
  • loss of appetite
  • blood-stained sputum
Show 7 more
  • chills
  • fever
  • rhinorrhea
  • stomatitis
  • drowsiness
  • chest tightness
  • irritation of the trachea and bronchi

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and should be kept in a cool room away from direct sunlight, specifically at temperatures between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

A colorless, transparent solution in a colorless, translucent plastic container.

Package unit

10 bottles/box[((8mL/bottle)x5) x 2], 10 bottles/box[((3mL/bottle)x5) x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.